Fe0-MAP Prepared Glycosurfaces for Selective Cell Capture: From Adherent to Suspended Cells
Source abstract
Abstract
The specific capture of live cells is crucial for various biomedical applications. Existing methods often are limited by complex production processes. This study introduces Fe 0 -mediated monomer-adaptation polymerization (Fe 0 -MAP), a convenient and rapid synthesis approach for selective cell capture using surface-engineered glycopolymer brushes. This method utilizes surface-initiated zerovalent iron-mediated reversible-deactivation radical polymerization (Fe 0 -SI-RDRP), offering advantages like simplicity, biocompatibility and oxygen-tolerance due to the use of iron sheet as catalysts. We successfully employed Fe 0 -MAP to selective capture both adherent (HeLa, L929) and suspended cells (Ramos, U937) in mammalian cell cultures. Combining excellent biocompatibility, specific and reusable cell capture capabilities, and applicability to suspended cells, Fe 0 -MAP establishes itself as a promising strategy for selective cell capture, holding significant potential for diverse biomedical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Innovative Microfluidic and Catalytic Techniques Innovation · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, P. R. China
Nantong No.2 Middle School, 500 Changtai Road, Nantong 226300, P. R. China
Center for Soft Condensed Matter Physics and Interdisciplinary Research, Soochow University, Suzhou 215006, P. R. China
Funding
Soochow University · National Natural Science Foundation of China · Priority Academic Program Development of Jiangsu Higher Education Institutions
References (34)
Show source-provided references
1. 10.1038/4411179a10.1038/4411179a ↗
2. 10.1002/adhm.20170000310.1002/adhm.201700003 ↗
3. 10.1200/JCO.2017.35.6_suppl.e57910.1200/JCO.2017.35.6_suppl.e579 ↗
4. 10.1038/s41551-018-0294-y10.1038/s41551-018-0294-y ↗
5. 10.1038/nature0087710.1038/nature00877 ↗
6. 10.1039/C7CS00854F10.1039/C7CS00854F ↗
7. 10.1002/adfm.20240578610.1002/adfm.202405786 ↗
8. 10.1039/D3CS00842H10.1039/D3CS00842H ↗
9. 10.1016/j.jddst.2022.10399810.1016/j.jddst.2022.103998 ↗
10. 10.3390/biomedicines912192310.3390/biomedicines9121923 ↗
11. 10.1038/nmat394910.1038/nmat3949 ↗
12. 10.1002/anie.20170931310.1002/anie.201709313 ↗
13. 10.1039/C8SC05561K10.1039/C8SC05561K ↗
14. 10.1002/marc.20220088110.1002/marc.202200881 ↗
15. 10.1021/ja103009d10.1021/ja103009d ↗
16. 10.1039/D2CS00912A10.1039/D2CS00912A ↗
17. 10.1038/s41589-023-01502-310.1038/s41589-023-01502-3 ↗
18. 10.1021/ja105671410.1021/ja1056714 ↗
19. 10.1021/ja212023410.1021/ja2120234 ↗
20. 10.1021/acs.chemrev.5b0024710.1021/acs.chemrev.5b00247 ↗
21. 10.1021/acs.accounts.8b0066510.1021/acs.accounts.8b00665 ↗
22. 10.1021/acs.chemrev.0c0133810.1021/acs.chemrev.0c01338 ↗
23. 10.1002/anie.20210654410.1002/anie.202106544 ↗
24. 10.1021/acs.macromol.2c0055710.1021/acs.macromol.2c00557 ↗
25. 10.1021/acsanm.2c0163210.1021/acsanm.2c01632 ↗
26. 10.1016/j.cclet.2021.12.03210.1016/j.cclet.2021.12.032 ↗
27. 10.1002/adhm.20230153610.1002/adhm.202301536 ↗
28. 10.1002/anie.20240285310.1002/anie.202402853 ↗
29. 10.1021/jacs.9b1297410.1021/jacs.9b12974 ↗
30. 10.1021/acsmacrolett.2c0013810.1021/acsmacrolett.2c00138 ↗
31. 10.1039/D1PY01601F10.1039/D1PY01601F ↗
32. 10.1007/s10555-020-09898-310.1007/s10555-020-09898-3 ↗
33. 10.1021/ma00127a04210.1021/ma00127a042 ↗
34. 10.1002/macp.20140022710.1002/macp.201400227 ↗